School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Caris Life Sciences, Inc. CAI

Healthcare · Biotechnology

$29.70last close 2026-10-09 · market cap $8.39B · delayed data

Trailing returns

1M+23.60%
3M+66.20%
6M+54.69%
1Y-4.99%

Basis: Adjusted daily closes.

What it does

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms.

Open CAI in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies